MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 57 filers reported holding MEI PHARMA INC in Q3 2017. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $894,000 | -12.7% | 307,313 | -4.9% | 0.00% | -100.0% |
| Q2 2021 | $1,024,000 | +31.5% | 323,089 | +37.6% | 0.00% | 0.0% |
| Q1 2021 | $779,000 | +1.4% | 234,731 | -8.3% | 0.00% | 0.0% |
| Q4 2020 | $768,000 | +5020.0% | 255,843 | +5267.0% | 0.00% | – |
| Q3 2020 | $15,000 | -46.4% | 4,767 | -42.2% | 0.00% | – |
| Q2 2020 | $28,000 | +21.7% | 8,242 | -9.3% | 0.00% | – |
| Q4 2019 | $23,000 | +130.0% | 9,085 | +51.9% | 0.00% | – |
| Q3 2019 | $10,000 | -28.6% | 5,979 | +5.1% | 0.00% | – |
| Q2 2019 | $14,000 | -88.1% | 5,688 | -87.0% | 0.00% | – |
| Q3 2017 | $118,000 | -6.3% | 43,816 | -17.2% | 0.00% | – |
| Q2 2017 | $126,000 | +6200.0% | 52,892 | +17530.7% | 0.00% | – |
| Q2 2014 | $2,000 | -97.2% | 300 | -95.3% | 0.00% | – |
| Q1 2014 | $71,000 | +39.2% | 6,326 | 0.0% | 0.00% | – |
| Q4 2013 | $51,000 | -10.5% | 6,326 | +25.3% | 0.00% | – |
| Q3 2013 | $57,000 | +58.3% | 5,048 | 0.0% | 0.00% | – |
| Q2 2013 | $36,000 | – | 5,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 3,018,059 | $4,467,000 | 4.40% |
| CAXTON CORP | 885,560 | $1,426,000 | 1.56% |
| Vivo Capital, LLC | 9,784,422 | $15,753,000 | 1.43% |
| Sio Capital Management, LLC | 2,485,098 | $4,001,000 | 1.34% |
| BVF INC/IL | 5,046,272 | $8,124,000 | 0.76% |
| NEA Management Company, LLC | 8,533,072 | $13,738,000 | 0.72% |
| Boxer Capital, LLC | 2,913,091 | $4,690,000 | 0.32% |
| Perceptive Advisors | 3,030,440 | $4,879,000 | 0.13% |
| WASATCH ADVISORS LP | 5,070,718 | $8,164,000 | 0.08% |
| KNOTT DAVID M | 38,590 | $62,000 | 0.04% |